Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=ilal20 Leukemia & Lymphoma ISSN: 1042-8194 (Print) 1029-2403 (Online) Journal homepage: http://www.tandfonline.com/loi/ilal20 Inter-individual variation in imatinib disposition: any role for prevalent variants of CYP1A2, CYP2C8, CYP2C9, and CYP3A5 in Nigerian CML patients? Ayorinde Adehin, Babatunde A. Adeagbo, Martin A. Kennedy, Oluseye O. Bolaji, Tiwalade A. Olugbade, Rahman A. Bolarinwa & Muheez A. Durosinmi To cite this article: Ayorinde Adehin, Babatunde A. Adeagbo, Martin A. Kennedy, Oluseye O. Bolaji, Tiwalade A. Olugbade, Rahman A. Bolarinwa & Muheez A. Durosinmi (2018): Inter-individual variation in imatinib disposition: any role for prevalent variants of CYP1A2, CYP2C8, CYP2C9, and CYP3A5 in Nigerian CML patients?, Leukemia & Lymphoma, DOI: 10.1080/10428194.2018.1466291 To link to this article: https://doi.org/10.1080/10428194.2018.1466291 View supplementary material Published online: 09 May 2018. Submit your article to this journal View related articles View Crossmark data